Anhydrous Lithium Bromide segmentation by type distinguishes three principal grades—technical, pharmaceutical, and high‑purity. Technical grade, characterized by a purity of 99 % or higher, dominates the volume‑based share because it satisfies the bulk demand of absorption‑chiller manufacturers and large‑scale chemical processors. Its lower cost structure drives the majority of production capacity, contributing roughly 60 % of total market revenue. Pharmaceutical grade, with purity exceeding 99.9 % and stringent impurity limits, serves niche drug‑formulation and specialty‑chemical segments; despite its premium price, it accounts for about 15 % of sales due to limited but high‑value applications. High‑purity grade, positioned between the two, offers 99.5 % purity for advanced research and high‑performance optical uses, representing the remaining 25 % of market size. Collectively, these type sub‑segments define the supply chain complexity and price differentiation that underpin the overall Anhydrous Lithium Bromide market, informing both production planning and investment allocation. The pricing gradient between grades also influences downstream cost structures, where end‑users in refrigeration prioritize volume cost over purity, while pharmaceutical firms allocate larger CAPEX to secure the high‑grade material, reinforcing the revenue distribution observed across the type taxonomy.